Vai al contenuto principale della pagina

Safe and effective medicines for children [[electronic resource] ] : pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act / / Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Safe and effective medicines for children [[electronic resource] ] : pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act / / Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors Visualizza cluster
Pubblicazione: Washington, : National Academies Press, 2012
Descrizione fisica: 1 online resource (432 p.)
Disciplina: 615.1083
Soggetto topico: Pediatric pharmacology
Drugs - Safety measures
Soggetto genere / forma: Electronic books.
Altri autori: FieldMarilyn J (Marilyn Jane)  
BoatThomas F  
Note generali: Description based upon print version of record.
Nota di bibliografia: Includes bibliographical references and index.
Nota di contenuto: ""Front Matter""; ""Acknowledgments""; ""Reviewers""; ""Preface""; ""Contents""; ""Boxes, Figures, and Tables""; ""Abbreviations and Acronyms""; ""Summary""; ""1 Introduction""; ""2 Children's Growth and Development and Pediatric Drug Studies""; ""3 Policy Framework for BPCA and PREA""; ""4 Ethical Issues in Pediatric Drug Studies""; ""5 Safety and Efficacy Assessments in Studies Conducted Under BPCA and PREA""; ""6 BPCA, PREA, and Drug Studies with Neonates""; ""7 Outcomes of Written Requests, Requirements, Studies, and Labeling Changes""; ""8 Pediatric Studies of Biologics""; ""References""
""Appendix A: Study Activities, Methods, and Public Meetings""""Appendix B: Dissemination of Information from Pediatric Studies Conducted Under BPCA and PREA""; ""Appendix C: Biologics in Pediatrics""; ""Appendix D: Biologics Studied and Not Studied in Children""; ""Appendix E: Written Requests for Studies of Pediatric Hypertension: Longitudinal Changes in FDA Specifications""; ""Appendix F: Committee and Staff Biographies""; ""Index""
Titolo autorizzato: Safe and effective medicines for children  Visualizza cluster
ISBN: 1-283-63634-4
0-309-22550-7
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910462065103321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui